Skip to main content
Erschienen in: BMC Cancer 1/2023

Open Access 01.12.2023 | Research

Disparities in oesophageal cancer risk by age, sex, and nativity in Kuwait:1980–2019

verfasst von: Saeed Akhtar, Ahmad Al-Shammari, Mohammad Al-Huraiti , Fouzan Al-Anjery, Salman Al-Sabah, Anjum Memon, Iqbal Siddique

Erschienen in: BMC Cancer | Ausgabe 1/2023

Abstract

Background

This cross-sectional cohort study assessed the inequalities in oesophageal carcinoma risk by age, sex and nativity in Kuwait: 1980–2019.

Methods

Using oesophageal cancer incidence data from the Kuwait National Cancer Registry, relevant Kuwaiti population data and World Standard Population as a reference, age-standardized incidence rates (ASIR) (per 100,000 person-years) overall and by subcohorts were computed. The incident oesophageal cancer cases count was overdispersed with excessive structural zeros, therefore, it was analyzed using multivariable zero-inflated negative binomial (ZINB) model.

Results

Overall ASIR of oesophageal cancer was 10.51 (95% CI:  6.62-14.41). The multivariable ZINB model showed that compared with the younger age category (< 30 years), the individuals in higher age groups showed a significant (p < 0.001) increasing tendency to develop the oesophageal cancer.  Furthermore, compared with the non-Kuwaiti residents, the Kuwaiti nationals were significantly (p < 0.001) more likely to develop oesophageal cancer during the study period. Moreover, compared with 1980-84 period, ASIRs steadily and significantly  (p < 0.005) declined in subsequent periods till 2015-19.

Conclusions

A high incidence of oesophageal cancer was recorded in Kuwait, which consistently declined from 1980 to 2019. Older adults (aged ≥ 60 years) and, Kuwaiti nationals were at high risk of oesophageal cancer. Focused educational intervention may minimize oesophageal cancer incidence in high-risk groups in this and other similar settings. Future studies may contemplate to evaluate such an intervention.
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Oesophageal cancer remains an important public health concern globally owing to its aggressive nature with an overall 5-year relative survival rate around 20% [1]. Worldwide, oesophageal cancer is the sixth most common malignancy accounting for over 500,000 cancer deaths each year [2, 3]. Oesophageal squamous-cell carcinoma (OSCC) and oesophageal adenocarcinoma (OA) are the two main histologic types of oesophageal cancer. OSCC is the predominant histological type of oesophageal cancer worldwide and is more common in Asia, whereas OA is main histologic type in high income western countries [46]. The known risk factors for oesophageal cancer are tobacco smoking, excessive alcohol consumption, low fruit and vegetable intake, high intake of red meat, the consumption of very hot beverages, genetic factors, gastro-oesophageal reflux, and obesity [7, 8]. Over the past few decades, linear declines in oesophageal cancer incidence have been recorded worldwide [911], whereas, in some regions, its incidence has been stable [2, 9]. However, the recent global trends have not been assessed in many regions including the middle eastern countries specifically in Kuwait. Therefore, this cross-sectional cohort study assessed the secular trends in population-level oesophageal cancer risk by age, sex, and nativity (1980–2019) in Kuwait.

Methods

In this cross-sectional cohort study, oesophageal cancer incidence data were obtained either from the Kuwait Cancer Control Center Registry (1980–2016) or projected (2017 to 2019). For each oesophageal cancer patient, we obtained the date of birth, age (years) at diagnosis, sex (male, female) and nativity (Kuwaiti, non-Kuwaiti). Relevant Kuwaiti population data were obtained from Public Authority for Civil Information, Ministry of Interior, Kuwait. Mid-year population counts for each year and by subcohorts were defined as the person-years. Age-standardized incidence rates (ASIR) (per 100,000 person-years) of oesophageal cancer overall, by year for unstratified data and by the subcohorts defined by cross-classification of period of diagnosis (5-year groups), age at diagnosis (10-years age brackets), sex (male or female) and nativity (Kuwaiti or non-Kuwaiti) were computed using World Standard Population as a reference ([12]. The trends in ASIR (per 100,000 person-years) across age, sex, nativity and periods were evaluated.  Outcome variable i.e., count of incident oesophageal cancer cases was overdispersed with excessive structural zeros, therefore, it was analyzed using zero-inflated negative binomial (ZINB) model. Univariable and multivariable ZINB models were fitted to the data and ZINB models’ coefficients and their corresponding standard errors were used to compute both unadjusted and adjusted incidence rate ratios (IRR) and their 95% confidence intervals (CI) respectively, which were used for the models’ interpretation.

Results

During the study period, a total of 496 cases of oesophageal cancer in 12.8 million person-years at risk were diagnosed. Of these, 269 (54.23%) were OSCC, 147 (29.64%) AC and 80 (16.13%) cases were histopathological unspecified. Subsequently, all the histopathological types were grouped as oesophageal cancer cases. The overall ASIR (per 100,000 person-years) of oesophageal cancer during the study period was 10.51 (95% CI:  6.62-14.41). The ASIRs (per 100,000 person-years) by age, sex, nativity and time periods are shown in Fig. 1. The highest ASIR (per 100,000) of oesophageal cancer was among 70 years old or older individuals (ASIR = 33.66; 95% CI: 15.44, 52.18). The ASIR (per 100,000 person-years) of oesophageal cancer was higher among males (ASIR = 12.70; 95% CI: 6.21, 19.19) than females (ASIR = 8.33 ; 95% CI: 3.92, 12.73). The highest ASIR (per 100,000 person-years) of oesophageal cancer was observed during 5-year period of 1980-84 followed by a consistently declining trend in subsequent 5-year periods. This declining trend was consistent across males and females as well (Fig. 2).
The multivariable ZINB model revealed that compared with the individuals younger than 30 years, the oesophageal cancer risk significantly (p < 0.001) increased through the higher age groups (Table 1). The oesophageal cancer risk among males compared with females was only marginally significant (adjusted IRR = 1.22; 95% CI:  0.99, 1.49; p = 0.058). Furthermore, compared with the non-Kuwaiti residents, the Kuwaiti nationals were significantly at higher risk of developing oesophageal cancer during the study period (adjusted IRR = 1.83; 95% CI: 1.49, 2.24; p < 0.001). Moreover, compared with 1980-84 period, in each of the subsequent 5-year periods, adjusted IRRs showed a significant (p < 0.005) and nearly a consistent declining tendency (Table 1).
Table 1
Mutlivariable zero-inflated negative binomial model of esophageal cancer risk by age, sex, nativity and period in Kuwait:1980–2019
Characteristic
Unadjusted IRR *,a
95% CI**
Adjusted IRR
95% CI
p-value
Age (years) at diagnosis
     
 < 30
1.00
1.00
< 0.001
 30–39
2.81
0.94–8.35
2.11
1.06–4.22
< 0.001
 40–49
23.80
8.51–66.56
10.01
5.37–18.64
< 0.001
 50–59
69.45
25.62–188.62
33.89
18.49–62.09
< 0.001
 60–69
220.92
82.02–595.02
92.40
50.42–169.34
< 0.001
 ≥ 70
382.55
141.92–1031.18
262.52
143.52 – 480.20
< 0.001
Sex
     
 Female
1.00
1.00
 
 Male
1.51
0.77–2.94
1.22
0.99–1.49
  0.058
Nativity
     
 Non-Kuwaiti
1.00
1.00
< 0.001
 Kuwaiti
1.16
0.60–2.27
1.83
1.49–2.24
 
Period
     
 1980-84
1.00
1.00
 1985-89
0.54
0.18–1.56
0.60
0.42–0.85
0.004
 1990-94
0.13
0.05 – 0.39
0.11
0.08–0.15
< 0.001
 1995-99
0.13
0.05 – 0.39
0.08
0.06–0.12
< 0.001
 2000-04
0.06
0.02 – 0.18
0.05
0.04–0.08
< 0.001
 2005-09
0.05
0.02 – 0.16
0.04
0.03–0.06
< 0.001
 2010-14
0.06
0.02 – 0.19
0.04
0.03–0.06
< 0.001
 2015-19
0.01
0.00–0.03
0.01
0.01–0.02
< 0.001
*Incidence rate ratio, **CI: confidence interval; a IRR for study periods exhibited significant exponenatial increase
(Anderson-Darling goodness-of-fit statistic = 0.721; p = 0.204)

Discussion

The results showed that during the past four decades, the overall ASIR (per 100,000 person-years) of oesophageal cancer was 10.51 in Kuwait. This estimate is comparable with those recently reported in Eastern Asia (11.1), but is nearly twice as much of the estimates reported from South-Central Asia (4.8), sub-Saharan Africa (4.2) and other world regions [13]. This global variation in ASIRs of oesophageal cancer may be owing to varying lifestyle and dietary patterns. The two established risk factors for oesophageal cancer are excessive alcohol consumption and tobacco smoking. Parenthetically Kuwait ranks very high worldwide for tobacco consumption prevalence in men (33.7%) and women (4.7%) [14], with parallel high ASIRs of oesophageal cancer, which indeed fulfils the Bradford Hill’s criterion of ‘coherence’ for causal link between tobacco smoking and oesophageal cancer.
The multivariable ZINB model showed that increasing age was associated with the increasing trend in the oesophageal cancer risk, which reflects a cumulative effect of carcinogenic exposures. The modification of known risk factors for oesophageal cancer may lessen the risk later in the life. Moreover, males had marginally increased oesophageal cancer risk than females, which outwardly related to sex hormones and lifestyle factors including smoking and dietary factors [7, 8]. Additionally, over the past four decades, oesophageal cancer risk consistently declined in Kuwait. Towards the end of twentieth century oesophageal cancer risk had been increasing in both sexes in USA, Europe, Japan and China [15, 16], which in recent decades showed a declining trend in these regions as well [15]. Similarly, downward trends with varying magnitudes in oesophageal cancer incidence were recorded in Hong Kong [17], and China [18]. These declining trends in oesophageal cancer incidence ostensibly is due to varying distributions of contributory risk factors across different populations [15, 19]. For example, in Kuwait, tobacco smoking by any mode including cigarettes, cigars and pipes showed a consistently declining trend with varying rates (5–6%) from 2000 to 2018 and stabilized thereafter, which seems to concur with the decreasing trend of oesophageal cancer in Kuwait [20].
In conclusion, an overall high oesophageal carcinoma ASIR was recorded. ASIRs consistently declined from1980 to 2019. Older adults (≥ 60 years) and Kuwaiti nationals were high-risk groups for oesophageal cancer. An educational intervention based on the known risk factors may alleviate oesophageal carcinoma risk in this and similar settings. Future studies may contemplate to evaluate the effect of such an intervention.

Acknowledgements

The authors thank to the staff of Kuwait Cancer Control Center Registry and Public Authority for Civil Information, Ministry of Health, Kuwait for facilitation of the study by providing requisite oesophageal cancer and population data.

Declarations

The study protocol was approved (protocol number 7097/ 26-8-2018) by the Ethics Committee of Ministry of Health, Kuwait. The patients with oesophageal cancer gave initially their informed consent to in be included in the cancer registry and for the use of their de-identified information for research purpose. All methods in this study were carried out in accordance with relevant guidelines and regulations of Declaration of Helsinkifor medical research involving human subjects.
Not applicable.

Competing of interests

None declared.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
2.
Zurück zum Zitat Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed
3.
Zurück zum Zitat Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-Maro G, Finch P, Mlombe Y, Schüz J, McCormack V. Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health; 2021. Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-Maro G, Finch P, Mlombe Y, Schüz J, McCormack V. Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health; 2021.
4.
Zurück zum Zitat Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, Wang HHX, Chiu PWY, Ng EKW, Wu JCY, et al. Global incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci Rep. 2018;8(1):4522.CrossRefPubMedPubMedCentral Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, Wang HHX, Chiu PWY, Ng EKW, Wu JCY, et al. Global incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci Rep. 2018;8(1):4522.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149–58.CrossRefPubMed Hur C, Miller M, Kong CY, Dowling EC, Nattinger KJ, Dunn M, Feuer EJ. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149–58.CrossRefPubMed
6.
Zurück zum Zitat Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.CrossRefPubMed Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.CrossRefPubMed
7.
Zurück zum Zitat Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383–96.CrossRefPubMed Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383–96.CrossRefPubMed
8.
9.
Zurück zum Zitat Fernandes ML, Seow A, Chan YH, Ho KY. Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic asian country. Am J Gastroenterol. 2006;101(7):1430–6.CrossRefPubMed Fernandes ML, Seow A, Chan YH, Ho KY. Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic asian country. Am J Gastroenterol. 2006;101(7):1430–6.CrossRefPubMed
10.
Zurück zum Zitat Rosemurgy A, Wilfong C, Craigg D, Co F, Sucandy I, Ross S. The Evolving Landscape of Esophageal Cancer: a four-decade analysis. Am Surg. 2019;85(9):944–8.CrossRefPubMed Rosemurgy A, Wilfong C, Craigg D, Co F, Sucandy I, Ross S. The Evolving Landscape of Esophageal Cancer: a four-decade analysis. Am Surg. 2019;85(9):944–8.CrossRefPubMed
11.
Zurück zum Zitat Xie SH, Lagergren J. Time trends in the incidence of oesophageal cancer in Asia: variations across populations and histological types. Cancer Epidemiol. 2016;44:71–6.CrossRefPubMed Xie SH, Lagergren J. Time trends in the incidence of oesophageal cancer in Asia: variations across populations and histological types. Cancer Epidemiol. 2016;44:71–6.CrossRefPubMed
12.
Zurück zum Zitat Ahmad O, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age standardization of Rates: a New WHO Standard. In. Geneva: World Health Organization.; 2002. Ahmad O, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age standardization of Rates: a New WHO Standard. In. Geneva: World Health Organization.; 2002.
13.
Zurück zum Zitat Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69(9):1564–71.CrossRefPubMed Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69(9):1564–71.CrossRefPubMed
14.
Zurück zum Zitat Spatial temporal. Demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the global burden of Disease Study 2019. Lancet. 2021;397(10292):2337–60.CrossRef Spatial temporal. Demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the global burden of Disease Study 2019. Lancet. 2021;397(10292):2337–60.CrossRef
15.
Zurück zum Zitat Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, Negri E, La Vecchia C. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2008;122(5):1118–29.CrossRefPubMed Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, Negri E, La Vecchia C. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2008;122(5):1118–29.CrossRefPubMed
16.
Zurück zum Zitat Castro C, Bosetti C, Malvezzi M, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol. 2014;25(1):283–90.CrossRefPubMed Castro C, Bosetti C, Malvezzi M, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol. 2014;25(1):283–90.CrossRefPubMed
17.
Zurück zum Zitat Tse LA, Yu IT, Mang OW. Time trends of esophageal cancer in Hong Kong: age, period and birth cohort analyses. Int J Cancer. 2007;120(4):853–8.CrossRefPubMed Tse LA, Yu IT, Mang OW. Time trends of esophageal cancer in Hong Kong: age, period and birth cohort analyses. Int J Cancer. 2007;120(4):853–8.CrossRefPubMed
18.
Zurück zum Zitat Gao X, Wang Z, Kong C, Yang F, Wang Y, Tan X. Trends of Esophageal Cancer Mortality in Rural China from 1989 to 2013: An Age-Period-Cohort Analysis.Int J Environ Res Public Health2017, 14(3). Gao X, Wang Z, Kong C, Yang F, Wang Y, Tan X. Trends of Esophageal Cancer Mortality in Rural China from 1989 to 2013: An Age-Period-Cohort Analysis.Int J Environ Res Public Health2017, 14(3).
19.
Zurück zum Zitat Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):77–81.CrossRef Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):77–81.CrossRef
20.
Zurück zum Zitat World Bank. : Macrotrends: Kuwait smoking rate 2000–2018. In.; 2023. World Bank. : Macrotrends: Kuwait smoking rate 2000–2018. In.; 2023.
Metadaten
Titel
Disparities in oesophageal cancer risk by age, sex, and nativity in Kuwait:1980–2019
verfasst von
Saeed Akhtar
Ahmad Al-Shammari
Mohammad Al-Huraiti
Fouzan Al-Anjery
Salman Al-Sabah
Anjum Memon
Iqbal Siddique
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2023
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10770-0

Weitere Artikel der Ausgabe 1/2023

BMC Cancer 1/2023 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.